Concepedia

James E. Sheppeck

JE

20

Publications

645

Citations

15

H-Index

1989

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Ironwood Pharmaceuticals (United States)

University of California, Irvine

Rockefeller University

James E. Sheppeck is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, biochemistry, and drug discovery.

Top concepts

Publications per year

1989–2025

20

Publications

20

A convenient and scaleable procedure for removing the Fmoc group in solution

James E. Sheppeck, Heidi Kar, Hui Hong · Tetrahedron Letters · 2000 · 79 citations

,

Conversion of Allylic Alcohols into Allylic Nitromethyl Compounds via a Palladium-Catalyzed Solvolysis:  An Enantioselective Synthesis of an Advanced Carbocyclic Nucleoside Precursor<sup>1</sup>

Donald R. Deardorff, Kenneth A. Savin, Craig Justman et al. · The Journal of Organic Chemistry · 1996 · 61 citations

, , +14

Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease

Jenny Tobin, Daniel P. Zimmer, Courtney Shea et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 59 citations · Full text

Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)

James J.‐W. Duan, Lihua Chen, Zhonghui Lu et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 53 citations · Full text

, , +9

Total Synthesis of the Serine/Threonine-Specific Protein Phosphatase Inhibitor Tautomycin<sup>1</sup>

James E. Sheppeck, Wen Liu, A. Richard Chamberlin · The Journal of Organic Chemistry · 1997 · 49 citations

, , +16

Rows per page

1–5 of 20